Publications

All Altman Ay Benedict Cheroutre Croft Crotty Einav Eschweiler Grifoni Hedrick Hogan Kawakami Kronenberg Ley Lindestam Lisdestam Arlehamn Myers Pandurangan Peters Rao Reina Saphire Schmiedel Schoenberger Sette Seumois Sharma Shresta Vijayanand Von Herrath Weiskopf

Jan 01, 2019

Cancer Immunol Res

Leveraging TCR affinity in adoptive immunotherapy against shared tumor/self-antigens

Miller AM, Bahmanof M, Zehn D, Cohen EEW, Schoenberger SP

Nov 01, 2018

Cold Spring Harb Perspect Biol

Is it possible to develop cancer vaccines to neoantigens, what are the major challenges, and how can these be overcome? Targeting the right antigens in the right patients

Schoenberger SP

Oct 10, 2018

Front Immunol

Class-B CpG-ODN formulated with a nanostructure induces type I interferons-dependent and CD4+ T cell-independent CD8+ T-cell response against unconjugated protein antigen

Chiodetti AL, Sánchez Vallecillo MF, Dolina JS, Crespo MI, Marin C, Schoenberger SP, Allemandi DA, Palma SD, Pistoresi-Palencia MC, Morón G, Maletto BA

Jul 21, 2018

J Transl Med

Perspectives in melanoma: Meeting report from the melanoma bridge (30 November–2 December, 2017, Naples, Italy)

Ascierto PA, Puzanov I, Agarwala SS, Bifulco C, Botti G, Caracò C, Ciliberto G, Davies MA, Dummer R, Ferrone S, Gajewski TF, Garbe C, Luke JJ, Marincola FM, Masucci G, Mehnert JM, Mozzillo N, Palmieri G, Postow MA, Schoenberger SP, Wang E, Thurin M

Apr 03, 2017

J Clin Invest

T cells control the generation of nanomolar-affinity anti-glycan antibodies

Polonskaya Z, Deng S, Sarkar A, Kain L, Comellas-Aragones M, McKay CS, Kaczanowska K, Holt M, McBride R, Palomo V, Self KM, Taylor S, Irimia A, Mehta SR, Dan JM, Brigger M, Crotty S, Schoenberger SP, Paulson JC, Wilson IA, Savage PB, Finn MG, Teyton L

Apr 13, 2016

Sci Transl Med

The human vaccines project: a roadmap for cancer vaccine development

Romero P, Banchereau J, Bhardwaj N, Cockett M, Disis ML, Granoff G, Gilboa E, Hammond SA, Hershberg R, Korman AJ, Kvistborg P, Melief C, Mellman I, Palucka AK, Redchenko I, Robins H, Sallusto F, Schenkelberg T, Schoenberger S, Sosman J, Türeci Ö, Van den Eynde B, Koff W, Coukos G

May 01, 2015

Journal of Immunology

CD28 promotes plasma cell survival, sustained antibody responses and BLIMP-1 upregulation through its distal PYAP proline motif

Rozanski CH, Utley A, Carlson LM, Farren MR, Murray M, Russell LM, Nair JR, Yang Z, Brady W, Garrett-Sinha LA, Schoenberger SP, Green JM, Boise LH, Lee KP

Apr 01, 2015

Nature

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, Boegel S, Schrörs B, Vascotto F, Castle JC, Tadmor AD, Schoenberger SP, Huber C, Türeci Ö, Sahin U

Feb 01, 2015

Immunology and Cell Biology

FoxO3 is a negative regulator of primary CD8+ T-cell expansion but not of memory formation

Togher S, Larange A, Schoenberger SP, Feau S

Jan 01, 2015

Nature Medicine

Notch signaling maintains T cell memories

Miller AM, Schoenberger SP

Jan 01, 2015

Mucosal Immunology

Unique lamina propria stromal cells imprint the functional phenotype of mucosal dendritic cells

Vicente-Suarez I, Larange A, Reardon C, Matho M, Feau S, Chodaczek G, Park Y, Obata Y, Gold R, Wang-Zhu Y, Lena C, Zajonc DM, Schoenberger SP, Kronenberg M, Cheroutre H

Jun 01, 2013

Nature Immunology

T cell exhaustion: a means or an end?

Salek-Ardakani S, Schoenberger SP